Urinary PGE-M in Men with Prostate Cancer

Urinary PGE-M in Men with Prostate Cancer

Urinary PGE-M is a stable metabolite of prostaglandin E2 (PGE2). PGE2 is a product of the inflammatory COX signaling pathway and has been associated with cancer incidence and metastasis. Its synthesis can be inhibited by aspirin. We investigated the association of PGE-M with lethal prostate cancer i...

Full description

Bibliographic Details
Main Authors:	Maeve Kiely, Ginger L. Milne, Tsion Z. Minas, Tiffany H. Dorsey, Wei Tang, Cheryl J. Smith, Francine Baker, Christopher A. Loffredo, Clayton Yates, Michael B. Cook, Stefan Ambs
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Cancers
Subjects:	prostate cancer aspirin health disparity prostaglandin E metabolite cyclooxygenase inflammation
Online Access:	https://www.mdpi.com/2072-6694/13/16/4073

Similar Items

Aspirin use in obstetrics and gynecology: A comprehensive review of applications and considerations
by: Astrit M. Gashi, et al.
Published: (2023-12-01)

Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
by: ZHENG Lirong, et al.
Published: (2023-09-01)

Silica Nanoparticles Shed Light on Intriguing Cellular Pathways in Human Tracheal Smooth Muscle Cells: Revealing COX-2/PGE<sub>2</sub> Production through the EGFR/Pyk2 Signaling Axis
by: Wen-Bin Wu, et al.
Published: (2024-01-01)

Systemic Inflammation Indices and Association with Prostate Cancer Survival in a Diverse Patient Cohort
by: Maeve Bailey-Whyte, et al.
Published: (2023-03-01)

Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)

Aspirin, platelet inhibition and cancer prevention
by: Paola Patrignani, et al.
Published: (2018-11-01)

Research into New Molecules with Anti-Inflammatory Activity
by: Abel Vale, et al.
Published: (2023-03-01)

The overexpression of COX 2 in Wilms’ tumor
by: Sara Hashemi
Published: (2014-02-01)

The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells
by: Agnieszka Kulesza, et al.
Published: (2023-02-01)

Microfluidic whole blood testing of platelet response to pharmacological agents
by: Ruizhi Li, et al.
Published: (2017-07-01)

The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants
by: Natsuki Ohkawa, et al.
Published: (2024-03-01)

Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro
by: Matthew Thomas Ferreira, et al.
Published: (2021-04-01)

Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men
by: Maeve Kiely, et al.
Published: (2021-06-01)

Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer
by: César Picado, et al.
Published: (2020-10-01)

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action
by: Paola Patrignani, et al.
Published: (2024-02-01)

COVID-19 and non-steroid anti-inflammatory drugs
by: O.A. Loskutov, et al.
Published: (2023-06-01)

Evaluation of Cyclooxygenase-2 and Prostaglandin E2 Expression in Endometrial Tissue Following 8 Weeks of Swimming Exercise and Omega-3 Intake
by: fatemeh rashidpour, et al.
Published: (2023-03-01)

2-Styrylchromones Modulate Prostaglandins Production through the Inhibition of COX-2
by: Mariana Lucas, et al.
Published: (2022-11-01)

The Effect of Nettle Extract and Aerobic Training on the Gene Expression of COX-1 and COX-2 in Mice with Melanoma
by: Javid Esmaeelpour, et al.
Published: (2022-07-01)

Thrombin-Induced COX-2 Expression and PGE<sub>2</sub> Synthesis in Human Tracheal Smooth Muscle Cells: Role of PKCδ/Pyk2-Dependent AP-1 Pathway Modulation
by: Chien-Chung Yang, et al.
Published: (2023-10-01)

NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
by: Oluwafunke R. Kolawole, et al.
Published: (2022-01-01)

Platelet inhibition by low-dose aspirin is not influenced by body mass or weight
by: Sean P. Heffron, et al.
Published: (2022-11-01)

Exogenous oxygen is required for prostanoid induction under brain ischemia as evidence for a novel regulatory mechanism
by: Drew R. Seeger, et al.
Published: (2023-11-01)

Association of neighborhood gentrification with prostate cancer and immune markers in African American and European American men
by: Catherine M. Pichardo, et al.
Published: (2024-01-01)

Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
by: Linda L. Garland, et al.
Published: (2022-06-01)

Preeclampsia and aspirin
by: Tae Gyu Ahn, et al.
Published: (2023-05-01)

Effects of a Novel GPR55 Antagonist on the Arachidonic Acid Cascade in LPS-Activated Primary Microglial Cells
by: Soraya Wilke Saliba, et al.
Published: (2021-03-01)

Prostaglandin production in brain endothelial cells during the initiation of fever
by: Anna Eskilsson, et al.
Published: (2023-12-01)

Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4
by: Qingqing Huang, et al.
Published: (2022-01-01)

Regulations of Tumor Microenvironment by Prostaglandins
by: Jeffrey Z. Nie, et al.
Published: (2023-06-01)

Relative Deficiency of Anti-Inflammatory <i>N</i>-Acylethanolamines Compared to Prostaglandins in Oral Lichen Planus
by: Linda Rankin, et al.
Published: (2020-11-01)

An in vitro anti-inflammatory effect of Thai propolis in human dental pulp cells
by: Nutthapong KANTRONG, et al.
Published: (2023-06-01)

Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
by: Yumeng Zhang, et al.
Published: (2022-08-01)

The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial
by: Elham Khoshbin, et al.
Published: (2023-07-01)

Inducing cyclooxygenase-2 expression, prostaglandin E2 and prostaglandin F2α production of human dental pulp cells by activation of toll-like receptor-3, mitogen-activated protein kinase kinase/extracellular signal-regulated kinase and p38 signaling
by: Mei-Chi Chang, et al.
Published: (2024-04-01)

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients
by: Angel Lanas, et al.
Published: (2023-04-01)

Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
by: Kunio Yui, et al.
Published: (2022-08-01)

Ibuprofen in Therapeutic Concentrations Affects the Secretion of Human Bone Marrow Mesenchymal Stromal Cells, but Not Their Proliferative and Migratory Capacity
by: Agnieszka Kulesza, et al.
Published: (2022-02-01)

Hypertension in Pregnancy and Preeclampsia: Variation in Clinical Management Strategies Among Obstetric/Gynecologic Provider Type
by: Sharla Smith, et al.
Published: (2023-10-01)

Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis
by: Ellen Frejborg, et al.
Published: (2020-12-01)